Literature DB >> 20199277

Isolated pharmacomechanical thrombolysis plus primary stenting in a single procedure to treat acute thrombotic superior vena cava syndrome.

Gerard J O'Sullivan1, Jennifer Ni Mhuircheartaigh, David Ferguson, Eithne Delappe, Conor O'Riordan, Ann Michelle Browne.   

Abstract

PURPOSE: To report a combined procedure that opens the acutely thrombosed superior vena cava (SVC) to rapidly alleviate symptoms in seriously ill patients with SVC syndrome. CASE REPORTS: Four patients aged 54 to 63 years old with underlying malignancies were referred for treatment of SVC syndrome. All received isolated pharmacomechanical thrombolysis (IPMT) with tissue plasminogen activator delivered in a Trellis Peripheral Infusion System that removed obstructive clot in minutes versus the 24 to 48 hours required for traditional catheter-directed thrombolysis. In each case, stents were inserted immediately following IPMT in a combined procedure lasting <1 hour. Patients exhibited near-immediate relief of debilitating symptoms; completion venography demonstrated patent vessels with excellent blood flow.
CONCLUSION: Combining IPMT with immediate stenting during the same session is an effective method for managing acute thrombotic SVC syndrome and limiting the exposure time and number of interventions performed on seriously ill patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20199277     DOI: 10.1583/09-2940.1

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN: 1526-6028            Impact factor:   3.487


  2 in total

1.  Catheter-directed thrombectomy with the JETi8 in the treatment of acute superior vena cava syndrome.

Authors:  Raffaella Emsley; Claude Haller; Laure Arts
Journal:  J Vasc Surg Cases Innov Tech       Date:  2022-08-05

2.  Kissing Stents for Superior Vena Cava Syndrome Due to Mediastinal Fibrosis.

Authors:  Jérémy Bardet; Dominique Fabre; Philippe Brenot; Claire Watkins; Elie Fadel
Journal:  Open J Cardiovasc Surg       Date:  2018-05-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.